LEBWOHL DAVID (EVP, Chief Medical Officer) received a stock award from INTELLIA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/4/2025ACC: 0000950170-25-032125
Officer· EVP, Chief Medical Officer
Since Apr 2020
+104.91K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
104.91K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+43.20K
Price / share
—
Trade value
—
% of position
49.3%
3/1/2025
87.67K→130.87K
Total
Net shares
+43.20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2025 | A · Award | +43.20K | — | — | 49.3% | 87.67K | 130.87K |
| Total | +43.20K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
61.71K shares
Shares
+61.71K
Strike price
10.09
Held after
61.71K
Exercisable
—
3/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock61.71K shares | 3/1/2025 | A · Award | +61.71K | 10.09 | — | 61.71K |